These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Key factors in the rising cost of new drug discovery and development. Dickson M; Gagnon JP Nat Rev Drug Discov; 2004 May; 3(5):417-29. PubMed ID: 15136789 [No Abstract] [Full Text] [Related]
5. Drugs and the Washington climate. Durant TM Trans Am Clin Climatol Assoc; 1969; 80():196-204. PubMed ID: 4896316 [No Abstract] [Full Text] [Related]
6. Future drugs that will be lifesavers for the industry too. Bylinsky G Fortune; 1976 Dec; 94(6):153-6, 158, 162. PubMed ID: 1028679 [No Abstract] [Full Text] [Related]
7. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related]
8. Process analytical technology and ASTM Committee E55. Watts DC; Afnan AM; Hussain AS Stand News; 2004 May; 32(5):25-7. PubMed ID: 15146856 [No Abstract] [Full Text] [Related]
9. When the pharmacy and therapeutics committee decides. Garrison TJ Hosp Pharm; 1979 Sep; 14(9):506-7. PubMed ID: 10243912 [No Abstract] [Full Text] [Related]
12. [Round table discussion on the Scandinavian drug market: A common pharmacy and therapeutics committee is proposed in view of threats from abroad of lowered standards]. Nord Med; 1974 Jan; 89(1):3-5. PubMed ID: 4856475 [No Abstract] [Full Text] [Related]
13. [Towards a new drug management]. Hoffmann M; Ahlner J Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634 [No Abstract] [Full Text] [Related]
14. Drug selection: one overlooked aspect. Wertheimer AI Hosp Formul; 1976 Jun; 11(6):315-6. PubMed ID: 10236468 [No Abstract] [Full Text] [Related]
16. The P&T committee and drug use review. Provost GP Hosp Formul; 1979 May; 14(5):596, 594. PubMed ID: 10242199 [No Abstract] [Full Text] [Related]
17. Editorial: Good news. Am Fam Physician; 1974 Nov; 10(5):71, 73. PubMed ID: 4423090 [No Abstract] [Full Text] [Related]
18. Drug utilization reviews--a major responsibility of the P&T committee: an administrative overview. Godwin HN Hosp Formul; 1981 Jun; 16(6):609, 613-5. PubMed ID: 10251441 [No Abstract] [Full Text] [Related]
19. $50 M for drug comparisons could produce valuable results. Carroll J Manag Care; 2004 Apr; 13(4):9-10. PubMed ID: 15146713 [No Abstract] [Full Text] [Related]
20. Implications of pharmacogenomics for drug development. Kirk RJ; Hung JL; Horner SR; Perez JT Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]